FEDERAL STREET STRATEGIES, LLC

Lobbying for BRISTOL MYERS SQUIBB COMPANY · Global biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Health Issues

Access to prescription drugs. Drug Pricing reform/implementation. Monitor Food is Medicine initiatives. Monitor issues related to the FY2025 budget reconciliation process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.